Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEATRIX: GBS6 Vaccine in Healthy Pregnant Women and Their Infants
NCT07160244Phase 3Recruiting
- Sponsor
- Pfizer
- Start
- Aug 2025
- Primary completion
- Nov 2028
- Modality
- Split/Subunit Vaccines, Peptide-based Cancer Vaccines
- Countries
- 15
01
Overview
A Phase 3 trial of GBS6 in Group B streptococcal infection (GBS), sponsored by Pfizer. Started Aug 2025; status: recruiting.
02
Drugs
GBS6
03
Conditions
Group B streptococcal infection (GBS)
Beyond the preview
Go deeper on NCT07160244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07160244.